# MIdazolam Versus MOrphine in Acute Pulmonary Edema (MIMO Trial)

> **NCT02856698** · PHASE4 · TERMINATED · sponsor: **Alberto Dominguez-Rodriguez** · enrollment: 111 (actual)

## Conditions studied

- Acute Pulmonary Edema

## Interventions

- **DRUG:** Midazolam
- **DRUG:** Morphine

## Key facts

- **NCT ID:** NCT02856698
- **Lead sponsor:** Alberto Dominguez-Rodriguez
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-04-08
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 111 (ACTUAL)
- **Why stopped:** The study was stopped because of the adverse events
- **Last updated:** 2022-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02856698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02856698, "MIdazolam Versus MOrphine in Acute Pulmonary Edema (MIMO Trial)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02856698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*